SIA
ABBV icon

Stancorp Investment Advisers’s AbbVie ABBV Stock Holding History

Stancorp Investment Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		$817K Sell
13,951
-3,029
-18% -$183K 0.38% 74
2014
Q4 		$1.11M Buy
+16,980
New +$1.07M 0.51% 55

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Stancorp Investment Advisers's ABBV Position: Q1 2015 in Review

Stancorp Investment Advisers reduced its AbbVie (ABBV) stake by 18% in Q1 2015, selling an estimated $183K and leaving 13,951 shares worth $817K. The position accounts for 0.38% of the portfolio, ranked #74.

Stancorp Investment Advisers first reported a position in ABBV in Q4 2014 and has held it in 2 quarters since. The position peaked at $1.11M in Q4 2014. 1,600 funds tracked by Wall St. Rank hold ABBV as of Q1 2015.

  • Stancorp Investment Advisers held 13,951 shares of AbbVie worth $817K as of Q1 2015.
  • Stancorp Investment Advisers sold 3,029 AbbVie shares in Q1 2015, an estimated $183K.
  • AbbVie made up 0.38% of Stancorp Investment Advisers's portfolio in Q1 2015, its #74 holding.
  • Stancorp Investment Advisers first reported a position in AbbVie in Q4 2014 and has held it in 2 quarters since.
  • Stancorp Investment Advisers's AbbVie position peaked at $1.11M in Q4 2014.
  • 1,600 funds tracked by Wall St. Rank held AbbVie as of Q1 2015.

Based on Stancorp Investment Advisers's 13F filing for Q1 2015, filed 13 May 2015.